Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.21
Aug 11 (Reuters) - Sana Biotechnology Q2 net income USD -93.8 million. Q2 EPS USD -0.39 Q2 adjusted net income USD -38.927 million vs. IBES estimate USD -49.3 million Q2 operating expenses USD 94.975 million
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17